Human Liver Tissue MicroArray (Cancer metastasis)

Images

 
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 01. Liver Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - Human Liver Tissue Microarray (Cancer metastasis) [NBP2-30221] - 02. Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - Liver Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 04. Liver Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - Liver Combined Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - Liver Hepatocwellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 07. Liver Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 08. Liver hepatocellular carcinoma Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 09. Liver hepatocellular carcinoma Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 10. liver hepatocellular carcinoma Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 11. Liver hepatocellular carcinoma moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 12. Liver Hepatocellular Carcinoma Moderately Differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 13. Liver hepatocellular carcinoma well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 14. Liver hepatocellular carcinoma moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 15. Liver hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 16. Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 17. Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 18. Liver hepatocellular carcinoma, Poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 19. Liver hepatocellular carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 20. Liver hepatocellular carcinoma, Poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 21. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 22. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 23. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 24. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 25. Liver hepatocellular carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 26. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 27. Liver hepatocellular carcinoma, Poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 28. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 29. Liver hepatocellular carcinoma, Poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 30. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 31. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 32. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 33. Liver hepatocellular carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 34. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 35. Liver hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 36. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 37. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 38. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 39. Liver cholangiocarcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 40. Liver cholangiocarcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 41. Colon metastatic heptocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 42. Lung metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 43. Liver: cancer-metastasis-normal
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 44. adrenal gland metastatic hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 45. Lumbar Vertebra metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 46. Colon metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 47. Soft Tissue metastatic hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 48. Lymph node, metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 49. Soft Tissue, metastatic Chloangiocarcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 50. Lymph node, Metastatic Cholangiocarcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 51. Liver (adjacent to cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 52. Liver (adjacent to cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 53. Liver (adjacent to cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 54. Liver (adjacent to cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 55. Liver, adjacent to cancer
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 56. Liver, non-neoplastic liver (apart from cancer, match of #5)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 57. Liver (apart from cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 59. Liver (apart from cancer)
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer metastasis) [NBP2-30221] - 58. Liver apart from cancer

Product Details

Summary
Reactivity HuSpecies Glossary
Applications IHC-P

Order Details

Human Liver Tissue MicroArray (Cancer metastasis) Summary

Description
Microarray Panel:
Liver cancer-metastasis-normal
No. of samples 59
No. of patients 44
Core diameter 2.0 mm
Format:Formalin Fixed
Section thickness 4 micrometer
Core#
No.
Age Sex Organ Diagnosis pTNM Stage Months* Tissue
type
Image
1 41 M Liver hepatocellular carcinoma T3aN0M0 IIIA . 6
2 52 M Liver hepatocellular carcinoma T3aN0M0 IIIA . 6
3 56 M Liver hepatocellular carcinoma T1N0M0 I . 6
4 37 M Liver hepatocellular carcinoma T4NxM1 IVB . 6
5 32 M Liver combined hepatocellular carcinoma & cholangiocarcinoma T3aN0M0 IIIA . 6
6 57 M Liver hepatocellular carcinoma T3aN0M0 IIIA . 6
7 65 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
8 72 M Liver hepatocellular carcinoma, well differentiated & poorly differentiated T2N0M0 II . 6
9 58 F Liver hepatocellular carcinoma, well differentiated T2N0M0 II . 6
10 52 M Liver hepatocellular carcinoma, well differentiated T2N0M0 II . 6
11 40 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
12 67 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
13 20 M Liver hepatocellular carcinoma, well differentiated T4N0M0 IIIC . 6
14 48 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
15 47 M Liver hepatocellular carcinoma T1N0M0 I . 6
16 69 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
17 63 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
18 60 F Liver hepatocellular carcinoma, poorly differentiated T1N0M0 I . 6
19 66 F Liver hepatocellular carcinoma, well differentiated T2N0M0 II . 6
20 64 M Liver hepatocellular carcinoma, poorly differentiated T3bN0M0 IIIB . 6
21 64 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
22 54 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
23 65 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
24 41 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
25 57 F Liver hepatocellular carcinoma, well differentiated T1N0M0 I . 6
26 57 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
27 50 M Liver hepatocellularp carcinoma,, poorlyy differentiated T1N0M0 I . 6
28 43 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
29 60 F Liver hepatocellular carcinoma, poorly differentiated T4N0M0 IIIC . 6
30 64 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
31 52 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
32 54 M Liver hepatocellular carcinoma, moderately differentiated T3aN0M0 IIIA . 6
33 56 M Liver hepatocellular carcinoma, well differentiated T1N0M0 I . 6
34 77 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
35 38 M Liver hepatocellular carcinoma T2N0M0 II . 6
36 75 M Liver hepatocellular carcinoma, moderately differentiated T2N0M1 IVB . 6
37 43 M Liver hepatocellular carcinoma, moderately differentiated T3aN0M0 IIIA . 6
38 72 M Liver hepatocellular carcinoma, moderately differentiated T4N1M0 IVA . 6
39 60 F Liver cholangiocarcinoma T1N0M0 I . 6
40 58 M Liver cholangiocarcinoma T2N1M0 IVA . 6
41 51 M Colon metastatic hepatocellular carcinoma TxNxM1 IVB . 6
42 62 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6
43 61 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6
44 60 M Adrenal gland metastatic hepatocellular carcinoma TxNxM1 IVB . 6
45 39 M Lumbar vertebra metastatic hepatocellular carcinoma from #35 TxNxM1 IVB 22 6
46 75 M Colon metastatic hepatocellular carcinoma from #36 T2N0M1 IVB 0 6
47 43 M Soft tissue metastatic hepatocellular carcinoma from #37 TXNXM1 IVB 5 6
48 72 M Lymph node metastatic hepatocellular carcinoma from #38 T4N1M0 IVA 0 6
49 60 F Soft tissue metastatic cholangiocarcinoma from #39 TXNXM1 IVB 16 6
50 58 M Lymph node metastatic cholangiocarcinoma from #40 T2N1M0 IVA 0 6
51 57 M Liver non-neoplastic liver (adjacent to cancer, match of #6) . . . 3
52 72 M Liver non-neoplastic liver (adjacent to cancer, match of #8) . . . 3
53 58 F Liver non-neoplastic liver (adjacent to cancer, match of #9) . . . 3
54 52 M Liver non-neoplastic liver (adjacent to cancer, match of #10) . . . 3
55 67 M Liver non-neoplastic liver (adjacent to cancer, match of #12) . . . 3
56 32 M Liver non-neoplastic liver (apart from cancer, match of #5) . . . 3
57 63 F Liver non-neoplastic liver (apart from cancer, match of #17) . . . 3
58 65 F Liver non-neoplastic liver (apart from cancer, match of #23) . . . 3
59 57 F Liver non-neoplastic liver (apart from cancer, match of #25) . . . 3
60 . . Carbon . . . . .


Applications/Dilutions

Publications
Read Publications using
NBP2-30221 in the following applications:

Reactivity Notes

Human

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.

Details for Liver

Type
Tissue
Tissue Condition
Cancer metastasis

Alternate Names for Human Liver Tissue MicroArray (Cancer metastasis)

  • Liver lysate
  • liver lysates
  • Liver

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Tissue Micro Arrays are guaranteed for 1 year from date of receipt.

Publications for Liver Tissue Micro Array (NBP2-30221)(10)

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: IHC, IHC-P, MiAr.


Filter By Application
IHC
(1)
IHC-P
(7)
MiAr
(1)
All Applications
Filter By Species
Human
(3)
All Species
Showing Publications 1 - 10 of 10.
Publications using NBP2-30221 Applications Species
Khanal T, Choi K, Leung YK et al. Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer Sci Rep 2017 Sep 06 [PMID: 28878246] (MiAr, Human) MiAr Human
Hsu C, Chen Y, Su H et al. Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability. Journal of Cancer May 12 2017 [PMID: 28638452] (IHC, Human) IHC Human
Rajasekaran D, Jariwala N, Mendoza RG et al. Staphylococcal nuclease and tudor domain containing 1 (SND1) promotes hepatocarcinogenesis by inhibiting monoglyceride lipase (MGLL). J. Biol. Chem. 2016 Mar 20 [PMID: 26997225] (IHC-P) IHC-P
Srivastava J, Robertson CL, Gredler R et al. Astrocyte Elevated Gene-1 (AEG-1) Contributes to Nonthyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC). J. Biol. Chem. 2015 May 05 [PMID: 25944909] (IHC-P)

Details:
Human Liver Tissue Microarray /Cancer metastasis (Imgenex: IMH-360) containing 40 primary human hepatocellular carcinoma / HCC, 10 metastatic HCC and 9 normal adjacent liver samples was used for IHC-P analysis of I 5’-deiodinase/DIO1 and oncogene Astrocyte elevated gene-1 /AEG-1 proteins using avidin-biotin-peroxidase -DAB staining method.
IHC-P
Tavallai M, Hamed HA, Roberts JL et al. Nexavar/Stivarga and Viagra Interact to Kill Tumor Cells J. Cell. Physiol. 2015 Feb 20 [PMID: 25704960] (IHC-P)

Details:
Human Liver Tissue Microarray (Cancer metastasis) (Imgenex IMH-360) was used in IHC-P immunostaining application for the analysis of PDE5 / PDE5A and PDGFR using a mixture of PDGF R alpha and PDGF R beta antibodies. The immunoassay implicated an antigen retrieval steps and the the data is shown in Figure 2.
IHC-P
Zhu H, Berkova Z, Mathur R et al. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer Mol. Cancer Res. 2015 Feb 12 [PMID: 25678597] (IHC-P)

Details:
Human Liver Tissue Microarray (Cancer metastasis, Imgenex IMH-360) containing sections of human HCC and normal liver tissues were used for IHC-P staining for HuR/ELAVL1 or HUR1 protein using VECTASTAIN Elite ABC Kit - DAB based detection. Human HCC tumor tissue sections depicted significantly higher overall and cytoplasmic HuR1 immunostaining compared to normal liver tissue sections (Figure 6).
IHC-P
Yoo BK, Santhekadur PK, Gredler R et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology. 2011 May [PMID: 21520169] (IHC-P)

Details:
Liver cancer-metastasis normal (IMH-360) and matching liver cancer (IMH-318). IHC (paraffin): Tissues were stained with SND1 antibody, Fig 6C.
IHC-P
Yoo BK, Emdad L, Gredler R et al. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2010 May 4 [PMID: 20404171] (IHC-P)

Details:
1. IMH-360: (liver cancer-metastasis-normal tissue microarray): IHC (paraffin), the tissue microarray was probed with LSF (Late SV40 Factor), Fig 1B.
IHC-P
Yoo BK, Emdad L, Su ZZ et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009 Mar [PMID: 19221438]
Santhekadur PK, Akiel M, Emdad L, Gredler R. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFb signaling. FEBS Open Bio 2014 (IHC-P, Human)

Details:
TMAs were used to detect SND1 or AT1R expression (Fig 3D).
IHC-P Human

Reviews for Liver Tissue Micro Array (NBP2-30221) (0)

There are no reviews for Liver Tissue Micro Array (NBP2-30221). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Liver Tissue Micro Array (NBP2-30221) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Liver Products

Blogs on Liver.

Signalling Advances in Adiponectin Antibody Research
Adiponectin is an adipocytokine protein that positively regulates metabolism of lipids and glucose by suppressing glucose production from the liver, stimulating insulin sensitivity, and increasing the rate of fatty acid oxidation and glucose uptake. I...  Read full blog post.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Liver Tissue MicroArray (Cancer metastasis) and receive a gift card or discount.